Public trial registry of the CCC-Munich

Trial CAMN107DDE06

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
CAMN107DDE06
World
Full title
:

An open label, multi-center, single-arm study to evaluate the efficacy of nilotinib in adult patients with metastatic or unresectable GIST in first line treatment

World
EudraCT number
:
World
NCT number
:
World
Responsible organization
:
KUM - Med3 - Medizinische Klinik und Poliklinik III Lmu
Indications
Classification Code Description
- C15-C19 GIST
Trial design
World
Trial type
:
Interventional
Status
World
Status
:
Recruitment finished
Votes
World
Institutional review board - vote
:
Positive
World
BfArM - vote
:
Positive
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy line
:
1
World
Therapy
:

Nilotinib

Participants The lead of this trial has not explicitely given their approval for publishing the contact information of the principal investigators or specific contact persons.